Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of CNOT4 mRNA | affects expression | 21346803
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of CNOT4 mRNA | decreases expression | 17879257
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of CNOT4 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CNOT4 mRNA | increases expression | 16467188 19400957 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNOT4 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CNOT4 mRNA | increases expression | 19400957
|
C010327 |
salinomycin |
salinomycin results in decreased expression of CNOT4 mRNA | decreases expression | 19682730
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of CNOT4 mRNA | affects expression | 17555576
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of CNOT4 mRNA | increases expression | 19400957
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of CNOT4 mRNA | increases expression | 19400957
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of CNOT4 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNOT4 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CNOT4 mRNA | increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
9.83 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.83 | 14514962 11752688 15322242 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.38 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.37 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.37 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.80 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.77 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.43 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.82 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.82 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.33 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.01 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
2.01 | 19682730 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.01 | 19059307 18425577 19084267 19244106 19155303 19487384 11161223 20005174 19142967 18984771 18855134 20390343 16202921 19103187 18629630 19066611 17242785 21152245 19189210 19288272 20135344 17261762 16273361 19200415 20065188 19410462 18997820 19289846 18815881 17049068 18351453 21138602 17893378 16818667 19011961 15565566 19189212 17440819 19221464 19115204 18821012 16873071 15668708 20859285 20544844 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.87 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
1.85 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.11 | 20419170 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.88 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 18670907 16120746 18850075 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.78 | 14694615 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.07 | 17333356 16919318 11677210 15861022 17110522 16105132 17681005 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 15340226 16354765 8697196 15668235 12621046 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
10.03 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
10.03 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.72 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.72 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
4.16 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.16 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.06 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.06 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.21 | 17893378 16202921 19155303 20544844 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.06 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.64 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.64 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.39 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.92 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.58 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.88 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.88 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.25 | 12621046 15340226 16120746 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.19 | 17440010 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 18606429 15340226 16354765 8697196 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.17 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.77 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.66 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.32 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.32 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.27 | 18625569 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.35 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.35 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.35 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.89 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.89 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.89 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.26 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.48 | 18569708 18520028 18816296 20464547 20135361 17053015 20064080 6695378 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.48 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.48 | 11884234 19555203 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.15 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
6.97 | 19682730 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.97 | 11731420 19196723 19196722 16827153 14580682 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.99 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.58 | 15990972 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.40 | 16381670 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.64 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.59 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.28 | 11141357 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.44 | 19189210 19196722 19200415 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
4.36 | 14694615 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.99 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11399792 11118676 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.07 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.07 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.71 | 16919318 15861022 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.85 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.85 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
13.09 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
13.09 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.43 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.92 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.30 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.30 | 16712894 17572228 8653321 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.63 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.82 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |